Currently out of the existing stock ratings of Scott Henry, 107 are a BUY (86.99%), 16 are a HOLD (13.01%).

Scott Henry

Work Performance Price Targets & Ratings Chart

Analyst Scott Henry, currently employed at ALLIANCE GLOBAL PARTNERS, carries an average stock price target met ratio of 60.29% that have a potential upside of 49.16% achieved within 394 days. Previously, Scott Henry worked at ROTH MKM.

Scott Henry’s has documented 252 price targets and ratings displayed on 40 stocks. The coverage is on Healthcare, Financial Services, Utilities sectors.

Most recent stock forecast was given on VVOS, Vivos Therapeutics at 19-Nov-2024.

Wall Street Analyst Scott Henry

Analyst best performing recommendations are on INVO (INVO BIOSCIENCE).
The best stock recommendation documented was for LGND (LIGAND PHARMACEUTICALS) at 2/4/2021. The price target of $124.77 was fulfilled within 1 day with a profit of $12.41 (11.04%) receiving and performance score of 110.45.

Average potential price target upside

of $6529.88 (50.33%) on NBY (NOVABAY PHARMACEUTICALS).
of $38.38 (56.68%) on LGND (LIGAND PHARMACEUTICALS).
of $17.9 (39.28%) on LCI (LANNETT COMPANY).

ANIP ANI Pharmaceuticals CPRX Catalyst Pharmaceuticals CSBR Champions Oncology DCTH Delcath Systems LCI Lannett Company LGND Ligand Pharmaceuticals MYO Myomo RDHL Redhill Biopharma Ltd TNXP Tonix Pharmaceuticals Holding Corp VVOS Vivos Therapeutics AVDL Avadel Pharmaceuticals PLC BDSI BioDelivery Sciences International IRM Iron Mountain LMAT LeMaitre Vascular REPH Recro Pharma INVO INVO Bioscience TTNP Titan Pharmaceuticals ZSAN Zosano Pharma Corp ZYNE Zynerba Pharmaceuticals SRTS Sensus Healthcare VKTX Viking Therapeutics IONM Assure Holdings Corp ASRT Assertio Therapeutics DERM Journey Medical Corp INM InMed Pharmaceuticals KMPH KemPharm NTEC Intec Pharma Ltd SOLY Soliton RVPH Reviva Pharmaceuticals Holdings RNXT RenovoRx INDP Indaptus Therapeutics NBY NovaBay Pharmaceuticals VERO Venus Concept CGNT Cognyte Software Ltd DXR Daxor FBIO Fortress Biotech IRMD Iradimed Co LC LendingClub Corp MEDXF Medexus Pharmaceuticals SO Southern Company

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Vamil Divan (GUGGENHEIM)